X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (696) 696
Publication (102) 102
Patent (19) 19
Book Chapter (8) 8
Book / eBook (7) 7
Web Resource (4) 4
Book Review (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (451) 451
middle aged (271) 271
hematology (246) 246
aged (242) 242
adult (241) 241
oncology (219) 219
male (212) 212
female (208) 208
index medicus (154) 154
leukemia, myeloid, acute - drug therapy (141) 141
prognosis (128) 128
antineoplastic combined chemotherapy protocols - therapeutic use (125) 125
treatment outcome (114) 114
adolescent (111) 111
aged, 80 and over (111) 111
remission induction (110) 110
acute myeloid leukemia (99) 99
acute myelogenous leukemia (95) 95
acute myeloid-leukemia (92) 92
leukemia, myeloid, acute - mortality (88) 88
cytarabine - administration & dosage (86) 86
acute disease (81) 81
chemotherapy (75) 75
cancer (73) 73
aml (68) 68
antineoplastic agents - therapeutic use (68) 68
leukemia, myeloid, acute - genetics (65) 65
therapy (64) 64
leukemia (63) 63
survival analysis (63) 63
antineoplastic combined chemotherapy protocols - adverse effects (59) 59
survival rate (58) 58
article (57) 57
recurrence (55) 55
leukemia, myeloid, acute - therapy (54) 54
disease-free survival (50) 50
survival (50) 50
leukemia, myeloid, acute - pathology (48) 48
myelodysplastic syndrome (47) 47
myelodysplastic syndromes - drug therapy (46) 46
retrospective studies (45) 45
leukemia, myeloid, acute - diagnosis (43) 43
leukemia, myeloid - drug therapy (41) 41
research (41) 41
cytarabine (40) 40
young adult (40) 40
myelodysplastic syndromes (37) 37
time factors (35) 35
vidarabine - analogs & derivatives (33) 33
drug administration schedule (32) 32
hematology, oncology and palliative medicine (31) 31
risk factors (31) 31
cytarabine - adverse effects (30) 30
dose-response relationship, drug (30) 30
follow-up studies (30) 30
abridged index medicus (29) 29
age factors (29) 29
antineoplastic combined chemotherapy protocols - administration & dosage (29) 29
care and treatment (29) 29
cytogenetics (29) 29
cells (28) 28
hematopoietic stem cell transplantation (28) 28
myelodysplastic syndromes - mortality (28) 28
acute promyelocytic leukemia (27) 27
gemtuzumab ozogamicin (27) 27
hemic and lymphatic diseases (27) 27
vidarabine - administration & dosage (27) 27
multivariate analysis (26) 26
adults (25) 25
complete remission (25) 25
cytarabine - therapeutic use (25) 25
health aspects (25) 25
idarubicin - administration & dosage (25) 25
transplantation (25) 25
antineoplastic agents - adverse effects (24) 24
chronic lymphocytic-leukemia (24) 24
karyotyping (24) 24
leukemia, myeloid, acute - metabolism (24) 24
myelodysplastic syndromes - pathology (24) 24
relapse (24) 24
remission (24) 24
acute lymphoblastic-leukemia (23) 23
child (23) 23
acute leukemia (22) 22
colony-stimulating factor (22) 22
expression (22) 22
induction chemotherapy (22) 22
leukemia, promyelocytic, acute - drug therapy (22) 22
clinical trials as topic (21) 21
leukemia - drug therapy (21) 21
myelodysplastic syndromes - genetics (21) 21
older patients (21) 21
antibodies, monoclonal, humanized (20) 20
daunorubicin - administration & dosage (20) 20
induction therapy (20) 20
leukemia, myeloid - mortality (20) 20
diagnosis (19) 19
flow cytometry (19) 19
infusions, intravenous (19) 19
leukemia, myeloid - genetics (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 08/2016, Volume 91, Issue 8, pp. 824 - 846
Evidence suggest that even patients aged 70 or above benefit from specific AML therapy. The fundamental decision in AML then becomes whether to recommend... 
Leukemia, Myeloid, Acute - mortality | Leukemia, Myeloid, Acute - diagnosis | Risk Assessment | Humans | Aged, 80 and over | Aged | Disease Management | Leukemia, Myeloid, Acute - therapy
Journal Article
2008, Hematologic malignancies, ISBN 3540723021, x, 294
Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. Thus, several... 
Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Acute leukemia | Clinical & internal medicine
Book
American Journal of Hematology, ISSN 0361-8609, 08/2016, Volume 91, Issue 8, pp. 824 - 846
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2094 - 2095
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 09/2017, Volume 17, pp. S22 - S23
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 04/2019, Volume 60, Issue 5, pp. 1107 - 1109
Journal Article